DXN-SB 250mg/125mg Injection
Marketer
DS Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview DXN-SB 250mg/125mg Injection
The combination antibiotic injection, DXN-SB 250mg/125mg, combats bacterial infections by inhibiting microbial proliferation and spread. Administration must be solely by a healthcare provider. Consistent adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to recovery. Your doctor might order lab tests and diagnostics to monitor the medication's impact.
Uses of DXN-SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of DXN-SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of DXN-SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use DXN-SB 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How DXN-SB 250mg/125mg Injection works:
Ceftriaxone 250mg/Sulbactam 125mg (DXN-SB Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. The addition of Sulbactam counters bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside DXN-SB 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication DXN-SB 250mg/125mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering DXN-SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of DXN-SB 250mg/125mg Injection might reduce awareness, impair vision, and induce drowsiness or dizziness. Driving is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of DXN-SB 250mg/125mg Injection in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering DXN-SB 250mg/125mg Injection to individuals with severe hepatic impairment requires careful consideration and potential dosage modification. Patients with mild to moderate liver dysfunction, however, do not typically necessitate dosage alterations of DXN-SB 250mg/125mg Injection. Physician consultation is advised.
What if you forget to take DXN-SB 250mg/125mg Injection :
Omit a scheduled DXN-SB 250mg/125mg Injection? Seek immediate medical advice.
Facts to Know About DXN-SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently